A Rapid Method for Determining Arachidonic:eicosapentaenoic Acid Ratios in Whole Blood Lipids: Correlation with Erythrocyte Membrane Ratios and Validation in a Large Italian Population of Various Ages and Pathologies

Overview

Journal Lipids Health Dis

Publisher Biomed Central

Specialties Biochemistry
Endocrinology

Date 2010 Jan 29

PMID 20105293

Citations 20

Authors

Angela M Rizzo

Gigliola Montorfano

Manuela Negroni

Laura Adorni

Patrizia Berselli

Paola Corsetto

Klaus Wahle

Bruno Berra

Affiliations

Soon will be listed here.

Abstract

Background: Omega-3 and -6 polyunsaturated fatty acids (LCPUFA), are important for good health conditions. They are present in membrane phospholipids.The ratio of total n-6:n-3 LCPUFA and arachidonic acid:eicosapentaenoic acid (AA and EPA), should not exceed 5:1. Increased intake of n-6 and decreased consumption of n-3 has resulted in much higher, ca 10/15:1 ratio in RBC fatty acids with the possible appearance of a pathological "scenario". The determination of RBC phospholipid LCPUFA contents and ratios is the method of choice for assessing fatty acid status but it is labour intensive and time consuming.

Aims Of The Study: [i] To describe and validate a rapid method, suitable for large scale population studies, for total blood fatty acid assay; [ii] to verify a possible correlation between total n-6:n-3 ratio and AA:EPA ratios in RBC phospholipids and in whole-blood total lipids, [iii] to assess usefulness of these ratio as biomarkers of LCPUFA status.

Methods: 1 Healthy volunteers and patients with various pathologies were recruited.2 Fatty acid analyses by GC of methyl esters from directly derivatized whole blood total lipids and from RBC phospholipids were performed on fasting blood samples from 1432 subjects categorised according to their age, sex and any existing pathologies.AA:EPA ratio and the total n-6:n-3 ratio were determined.

Results: AA:EPA ratio is a more sensitive and reliable index for determining changes in total blood fatty acid and it is correlated with the ratio derived from extracted RBC phospholipids.

Conclusions: The described AA:EPA ratio is a simple, rapid and reliable method for determining n-3 fatty acid status.

Citing Articles

A New, Validated GC-PICI-MS Method for the Quantification of 32 Lipid Fatty Acids via Base-Catalyzed Transmethylation and the Isotope-Coded Derivatization of Internal Standards.

Vodrazka P, rimnacova L, Berkova P, Vojtisek J, Verner M, Moos M Metabolites. 2025; 15(2).

PMID: 39997729 PMC: 11857457. DOI: 10.3390/metabo15020104.

Omega-3 Index as a Sport Biomarker: Implications for Cardiovascular Health, Injury Prevention, and Athletic Performance.

Medoro A, Buonsenso A, Centorbi M, Calcagno G, Scapagnini G, Fiorilli G J Funct Morphol Kinesiol. 2024; 9(2).

PMID: 38804457 PMC: 11197025. DOI: 10.3390/jfmk9020091.

Serum lipidomic study of long-chain fatty acids in psoriasis patients prior to and after anti-IL-17A monoclonal antibody treatment by quantitative GC‒MS analysis with in situ extraction.

Guo X, Zhou J, Yu H, Cao H, Li X, Hu Q Lipids Health Dis. 2024; 23(1):6.

PMID: 38185620 PMC: 10773056. DOI: 10.1186/s12944-023-01999-6.

Vitamin D and ω-3 Polyunsaturated Fatty Acids towards a Personalized Nutrition of Youth Diabetes: A Narrative Lecture.

Cadario F Nutrients. 2022; 14(22).

PMID: 36432570 PMC: 9699239. DOI: 10.3390/nu14224887.

Vitamin D Repletion and AA/EPA Intake in Children with Type 1 Diabetes: Influences on Metabolic Status.

Savastio S, Pozzi E, Mancioppi V, Boggio Sola V, Carrera D, Antoniotti V Nutrients. 2022; 14(21).

PMID: 36364863 PMC: 9655859. DOI: 10.3390/nu14214603.

References

Fujioka S, Hamazaki K, Itomura M, Huan M, Nishizawa H, Sawazaki S . The effects of eicosapentaenoic acid-fortified food on inflammatory markers in healthy subjects--A randomized, placebo-controlled, double-blind study. J Nutr Sci Vitaminol (Tokyo). 2006; 52(4):261-5. DOI: 10.3177/jnsv.52.261. View

Rodriguez-Cruz M, Tovar A, Del Prado M, Torres N . [Molecular mechanisms of action and health benefits of polyunsaturated fatty acids]. Rev Invest Clin. 2005; 57(3):457-72. View

Nambi V, Ballantyne C . Combination therapy with statins and omega-3 fatty acids. Am J Cardiol. 2006; 98(4A):34i-38i. DOI: 10.1016/j.amjcard.2005.12.025. View

Folch J, Lees M, SLOANE STANLEY G . A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957; 226(1):497-509. View

Poppitt S, Kilmartin P, Butler P, Keogh G . Assessment of erythrocyte phospholipid fatty acid composition as a biomarker for dietary MUFA, PUFA or saturated fatty acid intake in a controlled cross-over intervention trial. Lipids Health Dis. 2005; 4:30. PMC: 1334191. DOI: 10.1186/1476-511X-4-30. View

Peet M, Murphy B, Shay J, Horrobin D . Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry. 1998; 43(5):315-9. DOI: 10.1016/s0006-3223(97)00206-0. View

Schwab J, Serhan C . Lipoxins and new lipid mediators in the resolution of inflammation. Curr Opin Pharmacol. 2006; 6(4):414-20. DOI: 10.1016/j.coph.2006.02.006. View

Ikemoto A, Ohishi M, Hata N, Misawa Y, Fujii Y, Okuyama H . Effect of n-3 fatty acid deficiency on fatty acid composition and metabolism of aminophospholipids in rat brain synaptosomes. Lipids. 2000; 35(10):1107-15. DOI: 10.1007/s11745-000-0626-7. View

Hornych A, Oravec S, Girault F, Forette B, Horrobin D . The effect of gamma-linolenic acid on plasma and membrane lipids and renal prostaglandin synthesis in older subjects. Bratisl Lek Listy. 2002; 103(3):101-7. View

10.

Granlund L, Larsen L, Nebb H, Pedersen J . Effects of structural changes of fatty acids on lipid accumulation in adipocytes and primary hepatocytes. Biochim Biophys Acta. 2005; 1687(1-3):23-30. DOI: 10.1016/j.bbalip.2004.11.009. View

11.

Hammamieh R, Chakraborty N, Miller S, Waddy E, Barmada M, Das R . Differential effects of omega-3 and omega-6 Fatty acids on gene expression in breast cancer cells. Breast Cancer Res Treat. 2006; 101(1):7-16. DOI: 10.1007/s10549-006-9269-x. View

12.

Dewailly E, Blanchet C, Gingras S, Lemieux S, Holub B . Cardiovascular disease risk factors and n-3 fatty acid status in the adult population of James Bay Cree. Am J Clin Nutr. 2002; 76(1):85-92. DOI: 10.1093/ajcn/76.1.85. View

13.

Fontani G, Corradeschi F, Felici A, Alfatti F, Bugarini R, Fiaschi A . Blood profiles, body fat and mood state in healthy subjects on different diets supplemented with Omega-3 polyunsaturated fatty acids. Eur J Clin Invest. 2005; 35(8):499-507. DOI: 10.1111/j.1365-2362.2005.01540.x. View

14.

Cazzola R, Russo-Volpe S, Miles E, Rees D, Banerjee T, Roynette C . Age- and dose-dependent effects of an eicosapentaenoic acid-rich oil on cardiovascular risk factors in healthy male subjects. Atherosclerosis. 2006; 193(1):159-67. DOI: 10.1016/j.atherosclerosis.2006.06.008. View

15.

Cao D, Xue R, Xu J, Liu Z . Effects of docosahexaenoic acid on the survival and neurite outgrowth of rat cortical neurons in primary cultures. J Nutr Biochem. 2005; 16(9):538-46. DOI: 10.1016/j.jnutbio.2005.02.002. View

16.

Harris W, von Schacky C . The Omega-3 Index: a new risk factor for death from coronary heart disease?. Prev Med. 2004; 39(1):212-20. DOI: 10.1016/j.ypmed.2004.02.030. View

17.

McNamara R, Carlson S . Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins Leukot Essent Fatty Acids. 2006; 75(4-5):329-49. DOI: 10.1016/j.plefa.2006.07.010. View

18.

Sands S, Reid K, Windsor S, Harris W . The impact of age, body mass index, and fish intake on the EPA and DHA content of human erythrocytes. Lipids. 2005; 40(4):343-7. DOI: 10.1007/s11745-006-1392-2. View

19.

Nishizawa H, Hamazaki K, Hamazaki T, Fujioka S, Sawazaki S . The relationship between tissue RBC n-3 fatty acids and pulse wave velocity. In Vivo. 2006; 20(2):307-10. View

20.

Whelan J . Antagonistic effects of dietary arachidonic acid and n-3 polyunsaturated fatty acids. J Nutr. 1996; 126(4 Suppl):1086S-91S. DOI: 10.1093/jn/126.suppl_4.1086S. View